U.S. flag

An official website of the United States government

NM_000834.5(GRIN2B):c.448A>G (p.Ile150Val) AND Intellectual disability, autosomal dominant 6

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Jun 29, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001172347.2

Allele description [Variation Report for NM_000834.5(GRIN2B):c.448A>G (p.Ile150Val)]

NM_000834.5(GRIN2B):c.448A>G (p.Ile150Val)

Gene:
GRIN2B:glutamate ionotropic receptor NMDA type subunit 2B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p13.1
Genomic location:
Preferred name:
NM_000834.5(GRIN2B):c.448A>G (p.Ile150Val)
HGVS:
  • NC_000012.12:g.13753879T>C
  • NG_031854.2:g.233134A>G
  • NM_000834.5:c.448A>GMANE SELECT
  • NP_000825.2:p.Ile150Val
  • NC_000012.11:g.13906813T>C
  • NM_000834.3:c.448A>G
Protein change:
I150V
Links:
dbSNP: rs796052570
NCBI 1000 Genomes Browser:
rs796052570
Molecular consequence:
  • NM_000834.5:c.448A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Intellectual disability, autosomal dominant 6 (MRD6)
Synonyms:
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES
Identifiers:
MONDO: MONDO:0013509; MedGen: C3151411; OMIM: 613970

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001335393Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 4, 2017)
de novoclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV004175269Genetics and Molecular Pathology, SA Pathology

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jun 29, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedde novoyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical application of whole-exome sequencing across clinical indications.

Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, Vertino-Bell A, Smaoui N, Neidich J, Monaghan KG, McKnight D, Bai R, Suchy S, Friedman B, Tahiliani J, Pineda-Alvarez D, Richard G, Brandt T, Haverfield E, Chung WK, Bale S.

Genet Med. 2016 Jul;18(7):696-704. doi: 10.1038/gim.2015.148. Epub 2015 Dec 3.

PubMed [citation]
PMID:
26633542

GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects.

Platzer K, Yuan H, Schütz H, Winschel A, Chen W, Hu C, Kusumoto H, Heyne HO, Helbig KL, Tang S, Willing MC, Tinkle BT, Adams DJ, Depienne C, Keren B, Mignot C, Frengen E, Strømme P, Biskup S, Döcker D, Strom TM, Mefford HC, et al.

J Med Genet. 2017 Jul;54(7):460-470. doi: 10.1136/jmedgenet-2016-104509. Epub 2017 Apr 4.

PubMed [citation]
PMID:
28377535
PMCID:
PMC5656050
See all PubMed Citations (3)

Details of each submission

From Institute of Human Genetics, University of Leipzig Medical Center, SCV001335393.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This variant was identified as de novo (maternity and paternity confirmed).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From Genetics and Molecular Pathology, SA Pathology, SCV004175269.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The GRIN2B c.448A>G variant is classified as LIKELY PATHOGENIC (PS4_Supporting, PS2, PM2) The GRIN2B c.448A>G variant is a single nucleotide change in exon 4/14 of the GRIN2B gene, which is predicted to change the amino acid isoleucine at position 150 in the protein to valine. This variant has been identified as a de novo variant in this patient as well as in one reported case (PMID:28377535) (PS2), and has also been reported in other individuals with intellectual disability (PMID:26633542) (PS4_supporting). This variant is absent from population databases (PM2). The variant has been reported in dbSNP (rs796052570) and in the HGMD database: CM1618931. It has been reported as likely pathogenic by other diagnostic laboratories (ClinVar Variation ID: 205709).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2025